$JANL Income Statement | Understand Stock

$JANL

$50.00 -$1.98 (3.81%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Revenues:
Logistics
Life Sciences and Manufacturing
Total Revenues
Forwarding expenses and cost of revenues
Forwarding expenses and cost of revenues
Logistics
Life Sciences and Manufacturing
Total forwarding expenses and cost of revenues
Revenues
Logistics
Life Sciences and Manufacturing
Total Revenues
Forwarding expenses and cost of revenues
Logistics
Life Sciences and Manufacturing
Total forwarding expenses and cost of revenues
Gross profit
Operating Expenses:
Selling, general and administrative
Amortization of intangible assets
Total Operating Expenses
Income from Operations
Other Items:
Interest expense net of interest income
Gain on Paycheck Protection Program loan forgiveness
Fair value adjustments to Rubicon investment (net of dividends)
Change in fair value of earnout
Change in fair value of mandatorily redeemable non-controlling interest
Other income (expense)
Income Before Income Taxes
Income tax benefit (expense)
Net income (loss)
Preferred stock dividends
Non-controlling interest dividends
Net Income Available to Common Stockholders
Net income per share:
Basic (in Dollars per share)
Diluted (in Dollars per share)
Net income per share attributable to common stockholders:
Basic (in Dollars per share)
Diluted (in Dollars per share)
Weighted average number of shares outstanding:
Basic (in Shares)
Diluted (in Shares)

Comments